Search Results - "Venanzi, F M"
-
1
Recombinant DNA Technology for Melanoma Immunotherapy: Anti-Id DNA Vaccines Targeting High Molecular Weight Melanoma-Associated Antigen
Published in Molecular biotechnology (01-11-2014)“…Anti-idiotypic MK2-23 monoclonal antibody (anti-Id MK2-23 mAb), which mimics the high molecular weight melanoma-associated antigen (HMW-MAA), has been used to…”
Get full text
Journal Article -
2
Co-expression of Flt-3 ligand gene ablates tumor immunity elicited by HER-2/neu DNA vaccine in transgenic mice
Published in Vaccine (14-05-2010)“…Abstract Fms-like tyrosine-kinase 3 ligand (Flt-3L), is a powerful hematopoyetic growth factor, known to modulate the immune response against delivered…”
Get full text
Journal Article -
3
Prognostic relevance of altered Fas (CD95)‐system in human breast cancer
Published in International journal of cancer (20-03-2000)“…The Fas ligand (FasL) and its receptor Fas (APO‐1 or CD95) are members, respectively, of the tumor necrosis factor family that, upon interaction with each…”
Get full text
Journal Article -
4
Long-term immunologic effects of thymectomy in patients with myasthenia gravis
Published in Journal of allergy and clinical immunology (01-05-1999)“…Background: Thymectomy (Tx) is a common therapeutic option to treat myasthenia gravis (MG), but its effects on the immune system are still obscure in humans…”
Get full text
Journal Article -
5
Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag
Published in Cytotherapy (Oxford, England) (2007)“…Background We have previously shown that xenogeneic DNA vaccines encoding rat neu and melanosomal differentiation Ag induce tumor immunity. Others have…”
Get full text
Journal Article -
6
Genetic immunization against neu/erbB2 transgenic breast cancer
Published in Cancer Immunology, Immunotherapy (01-12-1998)“…erbB2/neu, an overexpressed oncogene product, has been proposed as a human cancer vaccine target. In the present study, transgenic (rat neuNT oncogene) FVB/neu…”
Get full text
Journal Article -
7
Autoantibody to p185erbB2/neu oncoprotein by vaccination with xenogenic DNA
Published in Cancer Immunology, Immunotherapy : CII (01-12-1996)“…The passive transfer of antibodies and vaccination procedures against p185, the erbB2/neu oncoprotein, are approaches being explored for treatment of human…”
Get full text
Journal Article -
8
Residual DNA-bound proteins are a source of in vitro transcription inhibitor peptides
Published in Physiological chemistry and physics and medical NMR (1989)“…Enzymatic breakdown of residual proteins occurs at mild alkaline pH (pH optimum 8.5) as monitored by using radioiodinated, purified genomic DNA from calf…”
Get full text
Journal Article -
9
HER-2/neu Oncogene Sequence Revisited
Published in JNCI : Journal of the National Cancer Institute (04-12-2002)“…In the course of developing DNA vaccines for transgenic models of breast cancer, we cloned the second cystein-- rich domain (CRD-2) of the extracellular domain…”
Get full text
Journal Article -
10
neu/HER-2 cDNA vaccination and pregnancy loss
Published in Annals of the New York Academy of Sciences (01-11-1995)Get more information
Journal Article -
11
Nucleic acids in mummified plant seeds: biochemistry and molecular genetics of pre-Columbian maize
Published in Genetical research (01-12-1991)“…Nucleic acids fractions were isolated from pre-Columbian maize seeds and characterized using different approaches such as polyacrylamide gel electrophoresis,…”
Get more information
Journal Article -
12
Binding of feline immunodeficiency viral gag-p24 polypeptide to nonimmune Igs
Published in Immunology letters (01-06-1998)“…Available data on the existence of lentivirus proteins with properties of unconventional Ag for B cells, have been so far restricted to human immunodeficiency…”
Get full text
Journal Article -
13
Dendritic cell (DC) vaccination with low dose temozolomide phase I/II trial in melanoma patients: Preliminary data on peripheral blood regulatory t-cells (Treg) and DC-TEM8 expression modulations
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
14
-
15
Tumor endothelial marker 8 enhances tumor immunity in conjunction with immnization against differentiation Ag
Published in Cytotherapy (Oxford, England) (2007)“…We have previously shown that xenogenic DNA vaccines encoding rat neu and melanosomal differentiation Ag induce tumor immunity. Others have developed vaccines…”
Get full text
Journal Article -
16
Immunorecognition of ring skeleton of taxanes by chicken egg yolk antibodies
Published in Biological chemistry Hoppe-Seyler (01-06-1994)“…Anti-10 deacetylbaccatin III (DAB) antibodies (IgY) were elicited in hens immunized with a succinyl-DAB/BSA conjugate and extracted from egg yolk. As shown by…”
Get more information
Journal Article -
17
Altered Expression of FAS System Is Related to Adverse Clinical Outcome in Stage I-II Breast Cancer Patients Treated with Adjuvant Anthracycline-Based Chemotherapy
Published in Clinical cancer research (15-02-2004)“…Purpose: To determine the prognostic value of Fas receptor and Fas ligand (FasL) as apoptosis-related biomarkers in the context of chemoresponsiveness in…”
Get full text
Journal Article -
18
Binding of feline immunodeficiency viral gag-p24 polypeptide to nonimmune IgGs
Published in Immunology letters (01-06-1998)“…Available data on the existence of lentivirus proteins with properties of unconventional Ag for B cells, have been so far restricted to human immunodeficiency…”
Get full text
Journal Article -
19
Autoantibody to p185 erbB2/neu oncoprotein by vaccination with xenogenic DNA
Published in Cancer Immunology, Immunotherapy (23-01-1997)Get full text
Journal Article -
20
Binding of feline immunodeficiency viral gag-p24 polypeptide to nonimmunge Igs
Published in Immunology letters (01-06-1998)“…Available data on the existence of lentivirus proteins with properties of unconventional Ag for B cells, have been so far restricted to human immunodeficiency…”
Get full text
Journal Article